Clinical Trial Search Results - Adventist HealthCare

Skip to Content

Clinical Trial Search Results

Showing 1-10 of 11

Sorted By:

  • Doxorubicin Hydrochloride/Cyclophosphamide

    Study of how doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel work in treating patients with triple negative breast cancer.

  • IMpassion130

    Study evaluates the efficacy, safety, and pharmacokinetics of atezolizumab administered with nab-paclitaxel compared with placebo.

  • NRG-BR003

    Randomized phase III trial to study how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer.

  • PALLAS

    Study evaluating the addition of 2 years of palbocicilib to standard adjuvant endocrine therapy for patients with HR+/HER2 early breast cancer (EBC).

  • PATRICIA/ML29366

    Study will examine the safety and efficacy of pertuzumab in combination with high-dose trastuzumab in adult participants with HER2-positive MBC with CNS metastases and disease progression in the brain following radiotherapy.

  • SANDPIPER

    International, multicenter, randomized, double-blinded, placebo-controlled study designed to compare the efficacy and safety of taselisib + fulvestrant with that of placebo + fulvestrant in postmenopausal women.

  • STAR Cape+BKM120

    Study to determine the safety and effectiveness of BKM120 plus capecitabine in breast cancer patients with brain metastases.

  • SystHERs Registry

    This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).

  • USO 14052

    Phase 2, open-label, single arm, multicenter, 2-stage study of eribulin mesylate administered biweekly at 1.4 mg/m2 intravenously for the treatment of participants with HER2-negative metastatic breast cancer previously treated with 2 to 5 chemotherapy regimens.

  • USOR 13033

    A clinical research study to learn if the study drug, alisertib, in combination with chemotherapy (paclitaxel), can shrink or slow tumor growth in women.

Page of 2, showing trials 1-10 of 11

Clincal Trials & Research Studies

Local Health News - In Your Inbox

Join over 80k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!